• No results found

Monitoring immunosuppression after liver transplantation : development of individualized Bayesian limited sampling monitoring

N/A
N/A
Protected

Academic year: 2021

Share "Monitoring immunosuppression after liver transplantation : development of individualized Bayesian limited sampling monitoring"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Monitoring immunosuppression after liver transplantation : development of individualized Bayesian limited sampling monitoring

Langers, P.

Citation

Langers, P. (2012, January 31). Monitoring immunosuppression after liver transplantation : development of individualized Bayesian limited sampling monitoring. Retrieved from https://hdl.handle.net/1887/18423

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded

from: https://hdl.handle.net/1887/18423

Note: To cite this publication please use the final published version (if applicable).

(2)

Monitoring Immunosuppression after Liver Transplantation

UITNODIGING

voor het bijwonen van de openbare verdediging van het

proefschrift getiteld:

Monitoring Immunosuppression after Liver Transplantation;

Development of Individualized Bayesian Limited Sampling

Monitoring door Pieter Langers De promotie zal plaatsvinden

op dinsdag 31 januari 2012 om 15.00 uur in de Senaatskamer van het

Academiegebouw, Rapenburg 73 te Leiden.

U bent van harte welkom om de promotie bij te wonen.

Toegangskaarten kunt u aanvragen bij de paranimfen.

Receptie na afloop van de promotie is in de Brasserie

van de Faculty Club in het Academiegebouw.

Paranimfen:

Alexandra Langers a.m.j.langers@lumc.nl

Rob Michielsens rmichielsens@gmail.com U wordt erop geattendeerd dat

het tijdrovend is om in de omgeving van het Academiegebouw te parkeren.

Pieter Langers Koppestokstraat 23

2014 AM Haarlem plangers@hotmail.com

Monitoring Immunosupression after Liver Transplantation; Development of Individualized

Bayesian Limited Sampling Monitoring

Pieter Langers

Pieter Langers

Referenties

GERELATEERDE DOCUMENTEN

Peripheral blood cells were stained with HLA-A2.1 tetramers containing the tyrosinase368–376 peptide followed by staining with a panel of lineage antibodies, as described in

Blades and blade fragments seem to have been especially used for longitudinal motions, mainly on plant material (7/12). Flake and flake fragments are used in different motions on

This shape also occurs in the combination artefacts (see below). The shape is the result of intensive use in a repetitive abrasive motion, carried out from different angles. In

We then developed a new, accurate, flexible and precise method for cyclosporine monitoring in stable patients more than 6 months after liver transplantation based on an

De afgelopen jaren verschenen artikelen in de literatuur dat het beter zou zijn om cyclosporine niet te monitoren op dalspiegel (C0) maar op basis van de concentratie 2 uur na

Langers P, Cremers SCLM, den Hartigh J, Rijnbeek EMT, Ringers J, Lamers CBHW, Hommes DW, van Hoek B.. Individualized population pharmacokinetic model with limited sampling

Dalspiegelmonitoring van ciclosporine na levertransplantatie leidt tot overdosering en daardoor slechtere nierfunctie bij eenderde van de patiënten in vergelijking met doseren

Since expression of Serpins may facilitate the immune escape of HLA positive tumors, we next analysed the effect of Serpin expression on survival in cases with normal/partial